Research and development
View all storiesTL1A: Exploring a potentially important target for inflammatory bowel disease
Our scientists are investigating ways to modulate TL1A to potentially address inflammation and fibrosis associated with inflammatory bowel disease
October 9, 2024
Our former CEO Dr. Roy Vagelos honored for role in helping China combat hepatitis B
We’re proud of his recognition and our continued commitment to global health
July 16, 2024
What is One Pipeline?
How we’re advancing the best internal and external science to progress our pipeline for patients
May 30, 2024
A new foundation for future talent
We’re partnering with America’s largest HBCU to launch a collaborative biotechnology learning center
May 2, 2024
How MSD scientists are driving next-generation cancer research
Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth
April 4, 2024
In our commitment to R&D, the numbers speak for themselves
We follow the science where we can make the greatest difference
March 7, 2024
Harnessing innovative technology in drug discovery
MSD scientists explain how new technologies can accelerate the drug discovery process as we use the power of leading edge science to save and improve lives
November 16, 2023
Why cytomegalovirus (CMV) should be on your radar
Once you have CMV, it stays in your body for life.
November 14, 2023
Breaking new ground in the UK
We’re accelerating our global efforts and capabilities with our new London Discovery Research Centre and U.K. headquarters
November 10, 2023
Understanding adult pneumonia: causes, symptoms and risk factors
Pneumonia is an infection of the lungs that can cause serious complications
October 31, 2023
MSD’s legacy of antimicrobial innovation and action
Delivering on our commitment to fight infectious diseases for more than a century
October 12, 2023
Uniting research and manufacturing to help patients faster
The opening of our updated site in Ireland will increase collaboration and speed to market
October 5, 2023
Meet the scientist advancing respiratory health and inspiring women and Latino scientists
Dr. Carmen La Rosa is uncovering new ways to help people with respiratory conditions
October 3, 2023
Macrocyclic peptides: the next wave of drug discovery
MSD scientists say the “Goldilocks” chemical modality could lead to new ways to impact disease
September 18, 2023
Progress in ovarian cancer research starts with patients
Reflecting on the history of clinical research and our inspiration to continue innovating for ovarian cancer patients
August 29, 2023
Meet two women at the forefront of our HIV research
Two esteemed scientists share their motivations and hopes for the future of HIV research
July 19, 2023
Researching new uses for a therapy that targets cancer cells
MSD scientists are evaluating potential antibody-drug conjugate (ADC) targets across both blood cancers and solid tumors
July 17, 2023
Podcast: Why neuroscience is the ‘final frontier’
Listen as specialists from MSD discuss what they’re most excited about in researching potential treatments for neurologic disorders
July 13, 2023
Safeguarding the environment through green chemistry
When a manufacturing process doesn’t meet our standards, we build an award-winning, planet-friendly one
June 1, 2023
Individualized neoantigen therapies: exploring one medicine for one patient
Scientists are researching new ways to help train the immune system to fight cancer
April 13, 2023
Women in science? Absolutely
Strong career paths and cutting-edge science draw more women scientists -- like chemists and engineers -- to our small molecule process R&D team
February 3, 2023
VIDEO: Here for Good – When passion and curiosity fuel innovation
Hear how one of our scientists balances her work and family life to accelerate our groundbreaking research
February 3, 2023
Celebrating the life of trailblazing cardiovascular researcher Dr. Arthur Patchett
Over the course of his career with MSD, Dr. Patchett changed the treatment paradigm for cardiovascular disease
January 11, 2023
How antimicrobial resistance is threatening one of our most critical health tools
Why antibiotics are a critical medicine and how we can help protect them
November 8, 2022
MSD publishes 2021/2022 Environmental, Social & Governance (ESG) Progress Report
Letter from our chief executive officer and president, Rob Davis
August 30, 2022
Proteins in space: taking our research to the final frontier
MSD Research Laboratories scientist Paul Reichert works with the International Space Station to drive innovation
June 29, 2022
Why we're expanding and investing in our research and discovery efforts
Our commitment to innovation helps ensure a brighter future for patients everywhere
June 9, 2022
Here for Good: The human element inspiring our cancer research
Learn how one doctor turned his family connection to cancer into a career driven by scientific innovation
May 27, 2022
Innovation is key to combating antimicrobial resistance in Asia-Pacific
Investing in research and innovative solutions gives us the best chance to fight these ‘superbugs’
February 24, 2022
When the world needs us, together we rise to the challenge
MSD CEO & President Rob Davis shares news with colleagues about our investigational COVID-19 medicine
December 23, 2021
Innovation in the fast lane
MSD and Corning are two years into a joint effort to maximize data science, one of today’s hottest research fields
December 9, 2021
How one woman’s diverse team is driving innovation in science and medicine
Rebecca Ruck is breaking down silos and leveraging diversity to invent smarter and greener ways to produce medicine
January 28, 2021